190 related articles for article (PubMed ID: 37175919)
1. The Long Run towards Personalized Therapy in Non-Small-Cell Lung Cancer: Current State and Future Directions.
Genova C
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175919
[TBL] [Abstract][Full Text] [Related]
2. Sharpening the attack on non-small cell lung cancer.
Alexander A; Quincy B
JAAPA; 2016 Nov; 29(11):1-5. PubMed ID: 27787282
[TBL] [Abstract][Full Text] [Related]
3. Identification of driver mutations in lung cancer: first step in personalized cancer.
Planchard D
Target Oncol; 2013 Mar; 8(1):3-14. PubMed ID: 23371030
[TBL] [Abstract][Full Text] [Related]
4. [Advanced non-small cell lung cancer - pioneer in personalized oncology].
Saalfeld FC; Aust DE; Wermke M
Dtsch Med Wochenschr; 2023 Sep; 148(18):1166-1173. PubMed ID: 37657454
[TBL] [Abstract][Full Text] [Related]
5. Current status of research and treatment for non-small cell lung cancer in never-smoking females.
Saito S; Espinoza-Mercado F; Liu H; Sata N; Cui X; Soukiasian HJ
Cancer Biol Ther; 2017 Jun; 18(6):359-368. PubMed ID: 28494184
[TBL] [Abstract][Full Text] [Related]
6. Advancing personalized cancer medicine in lung cancer.
MacConaill LE
Arch Pathol Lab Med; 2012 Oct; 136(10):1210-6. PubMed ID: 23020726
[TBL] [Abstract][Full Text] [Related]
7. Personalizing therapy in advanced non-small cell lung cancer.
Villaruz LC; Burns TF; Ramfidis VS; Socinski MA
Semin Respir Crit Care Med; 2013 Dec; 34(6):822-36. PubMed ID: 24258572
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic targeting of polo-like kinase 1 using RNA-interfering nanoparticles (iNOPs) for the treatment of non-small cell lung cancer.
McCarroll JA; Dwarte T; Baigude H; Dang J; Yang L; Erlich RB; Kimpton K; Teo J; Sagnella SM; Akerfeldt MC; Liu J; Phillips PA; Rana TM; Kavallaris M
Oncotarget; 2015 May; 6(14):12020-34. PubMed ID: 25557168
[TBL] [Abstract][Full Text] [Related]
9. Gene immunotherapy for non-small cell lung cancer.
Nemunaitis JJ
Methods Mol Biol; 2009; 542():499-514. PubMed ID: 19565919
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
Li L; Zhu T; Gao YF; Zheng W; Wang CJ; Xiao L; Huang MS; Yin JY; Zhou HH; Liu ZQ
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27258253
[TBL] [Abstract][Full Text] [Related]
11. Toward personalized treatment approaches for non-small-cell lung cancer.
Wang M; Herbst RS; Boshoff C
Nat Med; 2021 Aug; 27(8):1345-1356. PubMed ID: 34385702
[TBL] [Abstract][Full Text] [Related]
12. [Consensus of Chinese experts on detection of related drive genes in target therapy of non-small cell lung cancer].
Wang E; Zhu M; Bu H; Chen J; Ding Y; Zhou X; Liang Z; Zhang X; Sun B; ; ; ;
Zhonghua Bing Li Xue Za Zhi; 2016 Feb; 45(2):73-7. PubMed ID: 26879425
[No Abstract] [Full Text] [Related]
13. Genetic alterations defining NSCLC subtypes and their therapeutic implications.
Pikor LA; Ramnarine VR; Lam S; Lam WL
Lung Cancer; 2013 Nov; 82(2):179-89. PubMed ID: 24011633
[TBL] [Abstract][Full Text] [Related]
14. Future directions in the treatment of non-small cell lung cancer.
Shepherd FA
Semin Oncol; 1994 Jun; 21(3 Suppl 4):48-62. PubMed ID: 8209277
[TBL] [Abstract][Full Text] [Related]
15. miR-137 impairs the proliferative and migratory capacity of human non-small cell lung cancer cells by targeting paxillin.
Bi Y; Han Y; Bi H; Gao F; Wang X
Hum Cell; 2014 Jul; 27(3):95-102. PubMed ID: 24243432
[TBL] [Abstract][Full Text] [Related]
16. SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).
Felip E; Garrido P; Trigo JM; López-Brea M; Paz-Ares L; Provencio M; Isla D;
Clin Transl Oncol; 2009 May; 11(5):284-9. PubMed ID: 19451061
[TBL] [Abstract][Full Text] [Related]
17. Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
Moreira AL; Thornton RH
Clin Lung Cancer; 2012 Sep; 13(5):334-9. PubMed ID: 22424871
[TBL] [Abstract][Full Text] [Related]
18. Lung cancer: how to face the revolution?
Morère JF; Penault-Llorca F
Target Oncol; 2013 Mar; 8(1):1-2. PubMed ID: 23443962
[No Abstract] [Full Text] [Related]
19. Epigenetics in non-small cell lung carcinomas.
Peralta-Arrieta I; Armas-López L; Zúñiga J; Ávila-Moreno F
Salud Publica Mex; 2019; 61(3):318-328. PubMed ID: 31276346
[TBL] [Abstract][Full Text] [Related]
20. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
